SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-323226
Filing Date
2021-11-08
Accepted
2021-11-08 17:28:04
Documents
8
Period of Report
2021-11-08

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d241160d6k.htm 6-K 27973
2 EX-99.1 d241160dex991.htm EX-99.1 180788
3 EX-99.2 d241160dex992.htm EX-99.2 96857
4 EX-99.3 d241160dex993.htm EX-99.3 170949
5 EX-99.4 d241160dex994.htm EX-99.4 20517
6 GRAPHIC g241160g1109024544809.jpg GRAPHIC 3303
7 GRAPHIC g241160g1109024545059.jpg GRAPHIC 2187
8 GRAPHIC g241160g94z17.jpg GRAPHIC 1922
  Complete submission text file 0001193125-21-323226.txt   508902
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 211389039
SIC: 2836 Biological Products, (No Diagnostic Substances)